IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q2 2020 Holdings

Filed 2020-08-12 | 11 holdings | $44.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$43.7M1,767,67697.4%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$349.5K17,706,9780.8%
Revolution Medicines Inc(RVMD)COM76155X100$251.8K7,977,3840.6%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$196.7K6,777,1510.4%
Constellation Pharmceticls I(CNST)COM210373106$181.8K6,051,3760.4%
Oric Pharmaceuticals Inc.(ORIC)COM68622P109$160.8K4,768,1810.4%
Gritstone Oncology Inc(2JQ)COM39868T105$11.3K1,700,9450.0%